...your health first  
THERAPEUTIC AREAS  print
Ovocan

WHAT IT IS
It is a therapeutic KIT used in the treatment of complicated and uncomplicated Candida vulvovaginitis, consisting of a topical formulation (vaginal suppositories) and a systemic formulation (oral capsules) in the same box. The KIT is fully patented by Galsor and represents a breakthrough in the treatment of vulvovaginitis, as it allows to treat the responsible etiologic agents, in both possible sites for development, namely; the intestine and the vulvovaginal tract.
WHEN TO USE
In patients showing a clinical picture and typical symptoms of vulvovaginitis: itching, burning, abnormal vaginal discharges, erythema and edema of the tissues.
The therapeutic KIT may be used during pregnancy and in concurrence with a possible antibiotic therapy.
The therapeutic kit is specifically indicated for the prophylaxis of relapses of vulvovaginitis, particularly those who experience the typical symptoms at or immediately after the menstrual flow.
HOW TO USE
ACUTE PHASE
UNCOMPLICATED CANDIDA VULVOVAGINITIS
Administer:
• 2 daily oral capsules, for 5 consecutive days
• 1 daily vaginal suppository, for 5 consecutive days
COMPLICATED CANDIDA VULVOVAGINITIS
RECURRENT AND SEVERE
Administer:
• 2 daily oral capsules, for 10 consecutive days
• 1 daily vaginal suppository, for 10 consecutive days
IN THE PREVENTION OF RELAPSES
(uncomplicated and complicated Candida vulvovaginitis, bacterial vaginosis, aerobe vaginitis and nonspecific vulvovaginitis)
Administer for four consecutive months:
• 1 daily oral capsule, for 10 consecutive days, starting administration from the first day of menstrual flow
• 1 daily vaginal suppository, for 5 consecutive days, starting administration from the last day of menstrual flow
OVOCAN IS SUITABLE FOR THE TREATMENT AND PREVENTION OF VULVOVAGINITIS IN PREGNANCY
It is recommended to take the oral capsules, in the morning on an empty stomach.
The two capsules can also be taken simultaneously.
It is recommended to introduce the suppository gently into the vagina to the maximum possible depth, in the evening before bedtime. Before introducing the suppository, it is appropriate to conduct a thorough washing of the vagina with preparations suitable for use.

HOW IT WORKS
The mechanism of action of the therapeutic OVOCAN KIT is very complex and relies on three basic principles, such as:
- the DETACHMENT of the pathogenic microorganism by cells of the vaginal mucosa;
- the INACTIVATION of the same pathogenic microorganisms both in the vaginal and intestinal environment;
- the RESTORATION of the normal physiological activity of the vaginal and intestinal mucosa.
In short, a special blend of hyaluronic acid with different molecular weights screened reversibly by a potent enzymatic inhibitor of the hyaluronidase, is able to penetrate also into the deeper layers of the vaginal mucosa, forming a septum of separation between the fungal hyphae of Candida and the mucosa cells, preventing, thus, the dissemination of mycotoxins and, in particular, of lytic enzymes that would otherwise destabilize the mucosal cells and nourish the inflammatory process.
The inactivation of pathogenic microorganisms (inhibition of their proliferative capacity), both in the vaginal and intestinal level, is operated by three different zymocins produced by the two yeasts present in the therapeutic KIT, which, in a specific and selective way, are able to enter the Candida cells through special receptors on their cell wall and membrane. The same zymocins, once entered into the pathogenic yeasts (Candida), stop some processes of DNA replication and therefore prevent their proliferation. In this way, not being able to reproduce themselves, the pathogenic yeasts succumb after a few hours. The Kluyveromyces F.M. B0399 yeast in the therapeutic OVOCAN KIT, producing large amounts of lactic acid in both the vaginal and intestinal level, can rapidly lower the pH (within physiological limits) and, thus, inhibit all pH sensitive pathogenic microorganisms.
The phase of restoration of normal physiological activity of intestinal and vaginal mucosa is to promote the restoration of specific beneficial microflora in tissue repair and in hormonal regulation and immune response.
WHAT ARE THE EXPECTED BENEFITS
Disappearance of symptoms (burning, itching, creamy-white discharges, etc..), eradication of responsible pathogenic microorganisms (especially Candida), from both possible sites for development and restoration of normal physiological activity of the vaginal and intestinal environment.
WHAT ARE THE EXPECTED BENEFITS COMPARED TO TRADITIONAL THERAPIES
The therapeutic OVOCAN KIT may be used during the period of pregnancy and concomitantly with a possible antibiotic therapy, it essentially reduces the frequency of relapses, allows to achieve high eradication rates, induces low rates of resistance to pathogenic microorganisms responsible for vulvovaginitis, gives a very good compliance to patients and contains costs in a timely manner. Additionally, it allows to restore the beneficial lactobacilli microflora and does not cause any systemic and/or local side effect.

 

  Ovocan Preview EN

Promozione Galsor Video Galsor
Master VAS 2015
Miti’ da sfatare e ‘raccomandazioni’ da conoscere
Il Master si articola in Corsi Teorico-Pratici, Letture Magistrali e Tavole Rotonde e ‘Quadra...Read more
GALSOR LANCIA DUE NUOVI PRODOTTI
SINUMER E IPERNASEFLU